TAMPA, Fla. (PRWEB) April 16, 2018
The Cognis Group (http://www.cognisgroup.com), an international innovation company specializing in all facets of intellectual property, commercialization, and foresight research, announces acquisition of Pharmalicensing.com, a global life sciences technology marketplace.
Pharmalicensing.com (http://www.pharmalicensing.com) is the largest repository of life science opportunities in the world, with over 23,000 licensable technologies. For more than 20 years, the company has fostered commercialization within the life science, pharmaceutical, and medical device industries – providing a forum for members to create awareness of technologies, explore hyper-targeted search results, engage relevant scouts, and benefit from opportunity assessment analytics.
The site is used by technology transfer officers, technology scouts, and business development professionals spanning 110 countries. In addition to these audiences, research universities and government institutions access the service free of charge, exponentially expanding the universe of potential partnerships.
Cognis Group CEO, Allen Clary, states, “Our goal is to help innovators large and small future proof their organization by providing intelligence that informs IP decisions. Adding Pharmalicensing.com to our portfolio allows us to be an invaluable partner for those seeking more self-directed solutions as an alternative to commissioning custom scouting and partnering searches through our team. This continues to fortify our position from the front-end of innovation where the transformative ideas for breakthroughs occur, all the way through commercialization success, helping companies better uncover and realize billion dollar market opportunities.”
ABOUT COGNIS GROUP
Cognis Group, based in the US and UK, provides organizations around the world with the business intelligence and experience they need to make important innovation decisions with confidence. With 20 years of experience, Cognis provides innovation intelligence services to Fortune 500 companies, research universities, institutions, and technology owners. http://www.cognisgroup.com